Rare diseases
Investigational molecules
Locations
Study of Zolbetuximab combined with Paclitaxel and Ramucirumab for patients with previously treated CLDN18.
BelgiumStudy of Cerebrolysin to improve arm function in patients recovering from ischemic stroke
RomaniaStudy of IMMUNOSTEM gene therapy using modified stem cells for newly diagnosed patients with type 1 diabetes who still produce insulin
ItalyStudy of MTX-463 compared to placebo to assess its safety and effectiveness in adults with idiopathic pulmonary fibrosis
BelgiumStudy of TYRA-300-B01 tablets in patients with low grade, intermediate risk non-muscle invasive bladder cancer who have FGFR3 gene changes
FranceStudy of dupilumab injections to reduce airway inflammation in adults aged 40-85 with chronic obstructive pulmonary disease
AustriaStudy of drug combination therapy for prevention of recurrent stroke in patients with acute ischemic stroke and atrial fibrillation
GermanySafety and feasibility study of fecal microbiota transplant in stage II-III non-small cell lung cancer patients treated with durvalumab, carboplatin, paclitaxel and rifaximin
SpainStudy comparing cetuximab with chemotherapy versus bevacizumab with chemotherapy in patients with advanced colorectal cancer who have wild-type RAS and right-sided tumors
GermanyEvaluating intravenous lidocaine with intrathecal morphine for pain control in patients undergoing major abdominal surgery through laparotomy
FranceStudy of dapagliflozin to prevent heart complications during lymphoma treatment in patients receiving first-line therapy
DenmarkStudy comparing ALG-000184 with tenofovir disoproxil in untreated adults with chronic hepatitis B virus infection
BulgariaTell us about your condition – we search every trial in Europe and connect you with the right site.
